With reference to intimation dated February 23, 2026, regarding the allotment of equity shares pursuant to the exercise of options under Employees Stock Option Plan 2008 (‘ESOP 2008’) and Management ESOP Plan 2018 (‘MESOP 2018’), Sai Life Sciences has informed that allotment of 10,000 ESOP shares was inadvertently omitted in the previously submitted intimation. The Board of Directors of the Company has approved and allotted 29,007 and 1,10,000 fully paid-up equity shares of Re 1 each upon exercise of options granted under ESOP 2008 and MESOP 2018 respectively vide their Board Meeting held on 22 February 2026. The total number of shares allotted stands revised accordingly. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed as Annexure-A. Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024 are enclosed as Annexure-B.

The above information is a part of company’s filings submitted to BSE.